P Erne

Summary

Affiliation: Kantonsspital Luzern
Country: Switzerland

Publications

  1. ncbi The road to bioabsorbable stents: reaching clinical reality?
    Paul Erne
    Division of Cardiology, Kantonsspital Luzern, Luzern 16 CH 6000, Switzerland
    Cardiovasc Intervent Radiol 29:11-6. 2006
  2. pmc Noninvasive detection of left-ventricular systolic dysfunction by acoustic cardiography in atrial fibrillation
    Roger Dillier
    Division of Cardiology, Luzerner Kantonsspital, 6000 Luzern 16, Switzerland
    Cardiol Res Pract 2011:173102. 2010
  3. ncbi Sequential use of bare-metal stents and drug-coated balloons to treat coronary artery stenosis
    Remo Beeler
    Department of Cardiology, Luzerner Kantonsspital, Lucerne, Switzerland
    J Invasive Cardiol 24:555-9. 2012
  4. ncbi Good efficacy of drug-eluting balloons in a mixed population of patients with coronary artery disease
    Florim Cuculi
    Department of Cardiology, Luzerner Kantonsspital, 6000 Luzern 16, Switzerland
    J Invasive Cardiol 24:151-3. 2012
  5. doi [Treatment of acute coronary syndromes]
    Paul Erne
    Abteilung Kardiologie, Luzerner Kantonsspital, Luzern
    Ther Umsch 66:309-16. 2009
  6. ncbi Brachytherapy: potential therapy for refractory coronary spasm
    Paul Erne
    Division of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    J Am Coll Cardiol 44:1415-9. 2004
  7. doi Beyond auscultation--acoustic cardiography in the diagnosis and assessment of cardiac disease
    P Erne
    Head of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    Swiss Med Wkly 138:439-52. 2008
  8. ncbi Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial
    Paul Erne
    Division of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    JAMA 297:1985-91. 2007
  9. pmc Inflammatory myopathy and severe rhabdomyolysis induced by leuprolide acetate therapy for prostate cancer: a case report
    Michael Bergner
    Department of Cardiology, Luzerner Kantonsspital, 6000 Luzern 16, Switzerland
    J Med Case Reports 5:409. 2011
  10. doi Is pretreatment with Beta-blockers beneficial in patients with acute coronary syndrome?
    F Cuculi
    Department of Cardiology, University Hospital Bern, Bern, Switzerland
    Cardiology 115:91-7. 2010

Detail Information

Publications63

  1. ncbi The road to bioabsorbable stents: reaching clinical reality?
    Paul Erne
    Division of Cardiology, Kantonsspital Luzern, Luzern 16 CH 6000, Switzerland
    Cardiovasc Intervent Radiol 29:11-6. 2006
    ..Preclinical and first clinical experiences with bioabsorbable magnesium stents are discussed...
  2. pmc Noninvasive detection of left-ventricular systolic dysfunction by acoustic cardiography in atrial fibrillation
    Roger Dillier
    Division of Cardiology, Luzerner Kantonsspital, 6000 Luzern 16, Switzerland
    Cardiol Res Pract 2011:173102. 2010
    ..Conclusions. Acoustic cardiography can be used for diagnosis of LV systolic dysfunction in atrial fibrillation...
  3. ncbi Sequential use of bare-metal stents and drug-coated balloons to treat coronary artery stenosis
    Remo Beeler
    Department of Cardiology, Luzerner Kantonsspital, Lucerne, Switzerland
    J Invasive Cardiol 24:555-9. 2012
    ..The aim of this study was to assess long-term outcomes of patients who received treatment with DCB and BMS and additionally study whether the order (BMS or DCB first) affected outcomes...
  4. ncbi Good efficacy of drug-eluting balloons in a mixed population of patients with coronary artery disease
    Florim Cuculi
    Department of Cardiology, Luzerner Kantonsspital, 6000 Luzern 16, Switzerland
    J Invasive Cardiol 24:151-3. 2012
    ..Drug-coated balloons (DCB) are being increasingly used in interventional cardiology and are established for the treatment of in-stent restenosis (ISR). It is unclear how effective they are in patients with de novo lesions...
  5. doi [Treatment of acute coronary syndromes]
    Paul Erne
    Abteilung Kardiologie, Luzerner Kantonsspital, Luzern
    Ther Umsch 66:309-16. 2009
    ..The article also reviews quality assurance in Switzerland (AMIS Plus Registry). Potential future perspectives in the treatment of acute coronary syndromes are shown...
  6. ncbi Brachytherapy: potential therapy for refractory coronary spasm
    Paul Erne
    Division of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    J Am Coll Cardiol 44:1415-9. 2004
    ..We sought to demonstrate that brachytherapy reduces coronary spasm in refractory and highly symptomatic variant angina...
  7. doi Beyond auscultation--acoustic cardiography in the diagnosis and assessment of cardiac disease
    P Erne
    Head of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    Swiss Med Wkly 138:439-52. 2008
    ..It can also be used in a wide variety of ambulatory and inpatient monitoring applications...
  8. ncbi Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial
    Paul Erne
    Division of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    JAMA 297:1985-91. 2007
    ..The effect of a percutaneous coronary intervention (PCI) on the long-term prognosis of patients with silent ischemia after a myocardial infarction (MI) is not known...
  9. pmc Inflammatory myopathy and severe rhabdomyolysis induced by leuprolide acetate therapy for prostate cancer: a case report
    Michael Bergner
    Department of Cardiology, Luzerner Kantonsspital, 6000 Luzern 16, Switzerland
    J Med Case Reports 5:409. 2011
    ..abstract:..
  10. doi Is pretreatment with Beta-blockers beneficial in patients with acute coronary syndrome?
    F Cuculi
    Department of Cardiology, University Hospital Bern, Bern, Switzerland
    Cardiology 115:91-7. 2010
    ..The goal of this study was to analyze the role of pretreatment with beta-blockers in patients with ACS...
  11. doi BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial
    Matthias Pfisterer
    Department of Cardiology, University Hospital Basel, CH 4031 Basel, Switzerland
    JAMA 301:383-92. 2009
    ..It is uncertain whether intensified heart failure therapy guided by N-terminal brain natriuretic peptide (BNP) is superior to symptom-guided therapy...
  12. ncbi [Modern echocardiography: possibilities and limitations]
    M Zuber
    Kardiologie, Kantonsspital Luzern
    Praxis (Bern 1994) 95:895-901. 2006
    ..Three dimensional echocardiography is ready for clinical application. Good formation and continuous training in echocardiography according to international guidelines will help to reduce interobserver and intraobserver variability...
  13. doi Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompaction
    Richard Kobza
    Division of Cardiology, Luzerner Kantonsspital, Luzern, Switzerland
    Heart Rhythm 7:1545-9. 2010
    ..Therefore, the aim of the present study was to analyze the clinical outcome of a larger population of patients with LVNC who were treated with an ICD...
  14. doi Leisure-time activities of patients with ICDs: findings of a survey with respect to sports activity, high altitude stays, and driving patterns
    Richard Kobza
    Division of Cardiology, Cantonal Hospital, Luzern, Switzerland
    Pacing Clin Electrophysiol 31:845-9. 2008
    ..This study evaluates the habits of ICD patients with respect to sports activities, stays at high-altitude, and driving patterns...
  15. doi Implantable cardioverter-defibrillators in patients with left ventricular noncompaction
    Richard Kobza
    Division of Cardiology, Cantonal Hospital, Luzern, Switzerland
    Pacing Clin Electrophysiol 31:461-7. 2008
    ..The aim of the study was to analyze the clinical outcome of patients with LVNC who were treated with an implantable cardioverter-defibrillator (ICD)...
  16. doi Drug-eluting versus bare-metal stents in large coronary arteries
    Christoph Kaiser
    Department of Cardiology, University Hospital, CH 4031 Basel, Switzerland
    N Engl J Med 363:2310-9. 2010
    ..We sought to confirm this observation and to assess whether this increase in risk was also seen with second-generation drug-eluting stents...
  17. ncbi Is transesophageal echocardiography still necessary to exclude patent foramen ovale?
    M Zuber
    Division of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    Scand Cardiovasc J 42:222-5. 2008
    ..Current guidelines still recommend transesophageal echocardiography (TEE) as reference method to diagnose interatrial shunts. The aim was to test the accuracy of high-end transthoracal echocardiography (TTE) to exclude inter-atrial shunts...
  18. ncbi Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study
    Paul Erne
    Kantonsspital, Luzern, Switzerland
    Eur Heart J 28:2110-7. 2007
    ..To determine the effect of anti-ischaemic drug therapy on long-term outcomes of asymptomatic patients without coronary artery disease (CAD) history but silent exercise ST-depression...
  19. ncbi [What is your diagnosis? Brugada syndrome]
    R Kobza
    Abteilung Kardiologie, Kantonsspital Luzern
    Praxis (Bern 1994) 95:1825-7. 2006
  20. doi Serum procalcitonin has the potential to identify Staphylococcus aureus endocarditis
    F Cuculi
    Department of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    Eur J Clin Microbiol Infect Dis 27:1145-9. 2008
    ..We conclude that serum PCT has the potential to be used in the early diagnosis of S. aureus endocarditis...
  21. doi Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model
    D J Kurz
    Department of Internal Medicine, Division of Cardiology, Triemli Hospital, Birmensdorferstrasse 497, CH 8063 Zurich, Switzerland
    Heart 95:662-8. 2009
    ..Early risk stratification is important in the management of patients with acute coronary syndromes (ACS)...
  22. ncbi Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease
    Piero O Bonetti
    Division of Cardiology, University Hospital, Basel, Switzerland
    J Cardiovasc Pharmacol Ther 10:29-37. 2005
    ..Combined antianginal drug treatment represents the mainstay of therapy in this population. However, there is a paucity of data regarding the effect of this strategy on long-term outcome in the elderly...
  23. ncbi [Thrombolysis in acute myocardial infarct]
    P Erne
    Abteilung Kardiologie, Kantonsspital, Luzern
    Ther Umsch 48:527-34. 1991
    ....
  24. ncbi The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes
    F Cuculi
    Department of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    Cardiology 109:156-62. 2008
    ..The role of statin use in the treatment of acute coronary syndromes (ACS) is not clear. The aim of our study was to evaluate the role of statins in ACS...
  25. pmc Successful brachytherapy of coronary vasospasm
    T Chatterjee
    Division of Cardiology, Kantonsspital Luzern, Lucerne, Switzerland
    Heart 89:e25. 2003
    ..The standard treatment of patients with variant angina is to eliminate vasoconstrictive factors and to administer vasodilating drugs. This is the first description of successful brachytherapy for coronary spasm...
  26. ncbi [ECG diagnosis. What is your diagnosis?]
    R Kobza
    Abteilung Kardiologie, Kantonsspital Luzern
    Praxis (Bern 1994) 94:1669-70. 2005
  27. doi Functional mitral stenosis: a rare complication of the Impella assist device
    Stefan Toggweiler
    Division of Cardiology, Kantonsspital Luzern, CH 6000 Luzern 16, Switzerland
    Eur J Echocardiogr 9:412-3. 2008
    ..Although infrequent, this case shows a possible complication of the Impella ventricular assist device and highlights the importance of periodical echocardiographic surveillance, especially in patients who show a poor response to therapy...
  28. ncbi Psychological distress in patients with ICD recall
    Florim Cuculi
    Department of Cardiology, Kantonsspital Luzern, Switzerland
    Pacing Clin Electrophysiol 29:1261-5. 2006
    ..Exposure of ICD recipients to professional or media reports that their specific device type is potentially malfunctioning could negatively influence their psychological status...
  29. doi Significant decrease in in-hospital mortality and major adverse cardiac events in Swiss STEMI patients between 2000 and December 2007
    Valérie Stolt Steiger
    Division of Cardiology, Hopital Cantonal, Fribourg, Switzerland
    Swiss Med Wkly 139:453-7. 2009
    ..To evaluate the in-hospital outcome of STEMI (ST elevation myocardial infarction) patients admitted to Swiss hospitals between 2000 and December 2007, and to identify the predictors of in-hospital mortality and major cardiac events...
  30. ncbi ECG changes following cardioversion and defibrillation
    Florim Cuculi
    Department of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    Swiss Med Wkly 137:551-5. 2007
    ..changes of the QRS amplitude following defibrillation or cardioversion have never been reported in humans...
  31. ncbi Percutaneous transcatheter closure of coronary-pulmonary artery fistula using polytetrafluoroethylene-covered graft stents
    Christoph Auf der Maur
    Division Cardiology, Kantonsspital Luzern, 6000 Luzern 16, Switzerland
    J Invasive Cardiol 16:386-8. 2004
  32. doi Recorded heart sounds for identification of ventricular tachycardia
    Richard Kobza
    Division of Cardiology, Kantonsspital Luzern, Spitalstrasse, CH 6000 Luzern 16, Switzerland
    Resuscitation 79:265-72. 2008
    ..supraventricular tachycardia (SVT) is both important and often difficult. In this study, we tested the hypothesis that recorded digital cardiac acoustical data reflect hemodynamic changes that can be used for VT detection...
  33. doi Improved cardiac performance through pacing-induced diaphragmatic stimulation: a novel electrophysiological approach in heart failure management?
    Markus Roos
    Department of Cardiology, Kantonsspital, Luzern, Luzern, Switzerland
    Europace 11:191-9. 2009
    ..Here we investigate whether pacing-induced diaphragmatic stimulation (PIDS) may improve left ventricular (LV) systolic function...
  34. ncbi "Apical ballooning" - what is the cause?
    Sunil Wani
    Department of Cardiology, Luzerner Kantonsspital, Luzern, Switzerland
    J Invasive Cardiol 20:599-602. 2008
    ..This raises a strong suspicion of stress-induced endothelial dysfunction with hibernating myocardium in the pathogenesis of this cardiomyopathy...
  35. doi Noninvasive detection of left ventricular systolic dysfunction by acoustic cardiography in cardiac failure patients
    Markus Roos
    Division of Cardiology, Kantonsspital Luzern, Lucerne, Switzerland
    J Card Fail 14:310-9. 2008
    ..One parameter, the electromechanical activation time (EMAT), is prolonged in LVSD. We compared the abilities of acoustic cardiography, EF, and QRS duration to detect LVSD...
  36. doi Prevalence of long and short QT in a young population of 41,767 predominantly male Swiss conscripts
    Richard Kobza
    Division of Cardiology, Cantonal Hospital, Luzern, Switzerland
    Heart Rhythm 6:652-7. 2009
    ..Abnormally long and short QT intervals are recognized to be associated with an increased risk for life-threatening ventricular arrhythmias. It is therefore important to define the upper and lower border of the normal QT...
  37. doi Bacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab culture
    Martin Rohacek
    Department of Internal Medicine, Luzerner Kantonsspital, Luzern
    Circulation 121:1691-7. 2010
    ..Electrophysiological cardiac devices are increasingly used. The frequency of subclinical infection is unknown. We investigated all explanted devices using sonication, a method for detection of microbial biofilms on foreign bodies...
  38. ncbi Intravascular ultrasound-based left main coronary artery assessment: comparison between pullback from left anterior descending and circumflex arteries
    Yves Suter
    Department of Cardiology, Luzerner Kantonsspital, CH 6000 Luzern 16, Switzerland
    J Invasive Cardiol 21:457-60. 2009
    ..We compared continuous pullback from the left anterior descending artery (LAD) with pullback from the circumflex artery (CX) for the assessment of the left main coronary artery (LMCA) by intravascular ultrasound (IVUS)...
  39. ncbi Differences in coronary artery plaques between target and non-target vessels
    Stefan Toggweiler
    Division of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    J Invasive Cardiol 21:584-7. 2009
    ..We used intravascular ultrasound (IVUS) and virtual histology (VH) to assess the differences of plaque burden and composition between target coronary arteries containing the culprit lesion and non-target coronary arteries...
  40. ncbi End-of-life decisions in ICD patients with malignant tumors
    Richard Kobza
    Division of Cardiology, Kantonsspital Luzern, Switzerland
    Pacing Clin Electrophysiol 30:845-9. 2007
    ..Because the ICD reduces the incidence of sudden cardiac death, patients with these devices more often die of non-arrhythmic causes. For those with a malignancy, little is known about their preferences for disabling ICD therapy...
  41. ncbi Clinical correlates of very high brain natriuretic peptide levels in hospitalized patients
    Florim Cuculi
    Department of Cardiology Kantonsspital Luzern, Luzern, Switzerland
    Am Heart Hosp J 6:37-41. 2008
    ..Very high BNP values only poorly correlated with dyspnea and traditional echocardiographic markers of congestive heart failure. The clinical usefulness of very high BNP values is questionable and needs evaluation in a prospective trial...
  42. ncbi Implantable cardioverter-defibrillator malfunction with out-of-range lead measurements: What is the cause?
    Richard Kobza
    Division of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
    Heart Rhythm 4:106-7. 2007
  43. ncbi Staged stenting of a long aneurysm of a saphenous vein coronary artery bypass graft
    Peiman Jamshidi
    Division of Cardiology, Kantonsspital Lucerne, Lucerne, Switzerland
    J Invasive Cardiol 20:E1-5. 2008
    ..0 x 26 mm PTFE-covered stent at the distal edge of the previous stent. Final angiography and intravascular ultrasound showed no significant flow into the aneurysm...
  44. ncbi Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial
    Raimund Erbel
    West German Heart Center Essen, Department of Cardiology, Essen, Germany
    Lancet 369:1869-75. 2007
    ..We report a prospective multicentre clinical trial of coronary implantations of absorbable magnesium stents...
  45. doi Late coronary thrombosis following brachytherapy for vasospastic angina
    Cristina Basso
    Pathology, Department of Medico Diagnostic Sciences and Special Therapies, University of Padua Medical School, Padua, Italy
    Cardiovasc Pathol 17:244-5. 2008
  46. doi Comparison of in-hospital mortality for acute myocardial infarction in Switzerland with admission during routine duty hours versus admission during out of hours (insight into the AMIS plus registry)
    Alexandre Berger
    Service of Cardiology, Clinic Cecil, Lausanne, Switzerland
    Am J Cardiol 101:422-7. 2008
    ..Of predictors for in-hospital outcome, timing of admission had no significant influence on mortality and/or MACE incidence...
  47. doi Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study
    Andreas W Schoenenberger
    Department of Geriatrics, Inselspital University of Bern Hospital, Bern, Switzerland
    J Am Geriatr Soc 56:510-6. 2008
    ..To compare the use of guideline-recommended medical and interventional therapies in older and younger patients with acute coronary syndromes (ACSs)...
  48. ncbi Admission glycaemia and outcome in patients with acute coronary syndrome
    Damaris Müdespacher
    Acute myocardial infarction and unstable angina in Switzerland AMIS Plus Data Center, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    Diab Vasc Dis Res 4:346-52. 2007
    ..In conclusion, elevated glucose level in ACS patients on admission is a significant independent predictor of in-hospital mortality and is even more important for patients who do not have known diabetes...
  49. pmc Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry
    Dragana Radovanovic
    AMIS Plus Data Centre, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    Heart 93:1369-75. 2007
    ..Gender differences in management and outcomes have been reported in acute coronary syndrome (ACS)...
  50. ncbi Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trial
    Christoph Kaiser
    Department of Cardiology, University Hospitals Basel, Petersgraben 4, 4031 Basel, Switzerland
    Eur Heart J 25:1036-42. 2004
    ..To assess treatment effects of optimised medical therapy and PCI or CABG surgery on one-year outcome in patients 75 years old with chronic angina...
  51. ncbi Determinants of costs and the length of stay in acute coronary syndromes: a real life analysis of more than 10,000 patients
    Matthias Bramkamp
    Department of Internal Medicine, University Hospital of Zurich, RAE B 40, Ramistr 100, CH 8091 Zurich, Switzerland
    Cardiovasc Drugs Ther 21:389-98. 2007
    ..The aim of this study was to investigate inpatient costs of acute coronary syndromes (ACS) in Switzerland and to assess the main cost drivers associated with this disease...
  52. ncbi Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial
    Matthias Pfisterer
    Department of Cardiology, University Hospital, Petersgraben 4, CH 4031 Basel, Switzerland
    JAMA 289:1117-23. 2003
    ..The Trial of Invasive versus Medical therapy in Elderly patients (TIME) recently showed early benefits in quality of life from invasive therapy in patients aged 75 years or older, although with a certain excess in mortality...
  53. ncbi The economic efficiency of amlodipine in the treatment of coronary atherosclerosis--an analysis based on the PREVENT study
    Gieri Cathomas
    Medical Department, Hirslanden Research, Zurich, Switzerland
    Cardiovasc Drugs Ther 16:61-6. 2002
    ..The over-proportional increase in health service expenditure is obvious, compared to the increase in the costs of living...
  54. doi Prediction of arrhythmic events after myocardial infarction based on signal-averaged electrocardiogram and ejection fraction
    Andreas W Schoenenberger
    Department of General Internal Medicine, Inselspital University of Bern Hospital, Bern, Switzerland
    Pacing Clin Electrophysiol 31:221-8. 2008
    ..The aim of this study was to evaluate risk predictors based on a novel approach of interpreting signal-averaged electrocardiogram (SAECG) and ejection fraction (EF)...
  55. ncbi The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL
    Aleksandra A Korotaeva
    Cardiology Research Center, Moscow, Russia
    Mol Cell Biochem 270:107-13. 2005
    ..The data indicate that elevated serum sPLA2 activity after PTCA is associated with restenosis development and may be involved in atherogenic modification of LDL in blood serum...
  56. doi Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials
    Antonio Abbate
    Virginia Commonwealth University VCU Pauley Heart Center, Richmond, Virginia 23298, USA
    J Am Coll Cardiol 51:956-64. 2008
    ....
  57. ncbi Vascular risk factors in the Swiss population
    Krassen Nedeltchev
    Dept of Neurology, University Hospital of Bern, Freiburgstrasse 4, Switzerland
    J Neurol 252:1210-6. 2005
    ..Identification of the population at risk of stroke remains the best approach to assess the burden of cardiovascular morbidity and mortality...
  58. ncbi Percutaneous aspiration of inferior vena cava thrombus
    Paul Erne
    Cardiology Department, Kantonal Hospital, Lucerne, Switzerland
    J Invasive Cardiol 18:E149-51. 2006
  59. doi Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design
    Matthias Pfisterer
    Department of Cardiology, University Hospital Basel, Basel, Switzerland
    Am Heart J 155:609-14. 2008
    ....
  60. ncbi Ten-year trends in the incidence and treatment of cardiogenic shock
    Raban V Jeger
    University Hospital Basel, Switzerland
    Ann Intern Med 149:618-26. 2008
    ..Few studies describe recent changes in the incidence, treatment, and outcomes of cardiogenic shock...
  61. ncbi Cost-effectiveness of losartan versus atenolol in treating hypertension--an analysis of the LIFE study from a Swiss perspective
    Thomas D Szucs
    Institute of Social and Preventive Medicine, University of Zurich, Gloriastrasse 18a, CH 8006 Zurich, Switzerland
    Cardiovasc Drugs Ther 18:391-7. 2004
    ..To determine the economic benefit of losartan versus atenolol in patients with essential hypertension from the perspective of the Swiss healthcare system...
  62. ncbi Myocardial infarction after an ice-hockey match: coincidence of myocardial bridging and coronary spasm
    Peiman Jamshidi
    Int J Cardiol 113:e70-2. 2006
  63. ncbi Cost-effectiveness of eplerenone in patients with left ventricular dysfunction after myocardial infarction--an analysis of the EPHESUS study from a Swiss perspective
    Thomas D Szucs
    Institute of Social and Preventive Medicine, University of Zurich, Gloriastrasse 18a, CH 8006 Zurich, Switzerland
    Cardiovasc Drugs Ther 20:193-204. 2006
    ..The EPHESUS pharmacoeconomic analysis was performed to evaluate the cost-effectiveness of eplerenone in the Swiss setting...